Cosmos Health Expands AI Integration Across Operations And R&D To Boost Efficiency And Growth

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the continued integration of artificial intelligence (AI) across its operations, reflecting ongoing investments aimed at enhancing efficiency, reducing costs, improving customer experience, and driving sales growth.

AI is becoming an increasingly important component of Cosmos Health's operating model and a key enabler across multiple areas of its business, with initial efficiency gains already being realised. In certain areas, the Company believes that AI-driven optimisation may reduce specific operating expenses by up to 30%, depending on the process and level of automation.

Recent investments include the deployment of AI-driven solutions across the Company's front-end operations, order management and customer relationship handling. These systems function as intelligent agents that streamline order processing, enhance customer engagement, and improve responsiveness, while minimising errors and improving overall service quality.

The Company is also leveraging AI across its back-end operations, including warehouse optimisation, inventory management, and supply chain processes, improving stock visibility, increasing inventory efficiency, and reducing fulfilment errors. These initiatives are expected to support improved working capital management, cost reduction, enhanced customer satisfaction, and continued commercial growth.

In addition, the Company's broader AI strategy includes its proprietary Cloudscreen platform, which applies AI to drug repurposing and supports its research and development (R&D) pipeline. This dual application of AI across both its operational functions and R&D reinforces Cosmos Health's strategy to integrate technology across its vertically integrated platform. The Company continues to expand the use of AI and other advanced technologies, including its ongoing work in nanotechnology.